Outcomes of Thalassemia Patients Undergoing Hematopoietic Stem Cell Transplantation by Using a Standard Myeloablative versus a Novel Reduced-Toxicity Conditioning Regimen According to a New Risk Stratification

Improving outcomes among class 3 thalassemia patients receiving allogeneic hematopoietic stem cell transplantations (HSCT) remains a challenge. Before HSCT, patients who were ≥ 7 years old and had a liver size ≥ 5 cm constitute what the Center for International Blood and Marrow Transplant Research d...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biol Blood Marrow Transplant
Hauptverfasser: Anurathapan, Usanarat, Pakakasama, Samart, Mekjaruskul, Pimsiri, Sirachainan, Nongnuch, Songdej, Duantida, Chuansumrit, Ampaiwan, Charoenkwan, Pimlak, Jetsrisuparb, Arunee, Sanpakit, Kleebsabai, Pongtanakul, Bunchoo, Rujkijyanont, Piya, Meekaewkunchorn, Arunotai, Sruamsiri, Rosarin, Ungkanont, Artit, Issaragrisil, Surapol, Andersson, Borje S., Hongeng, Suradej
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2014
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5538782/
https://ncbi.nlm.nih.gov/pubmed/25064743
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2014.07.016
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge